HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Edward P. Chen Hartmuth B. Bittner Peter Van Trigt Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, E. P. Articles by Van Trigt, P. Search for Related Content PubMed PubMed Citation Articles by Chen, E. P. Articles by Van Trigt, P.

J Thorac Cardiovasc Surg 1997;113:849-857
© 1997 Mosby, Inc.

GENERAL THORACIC SURGERY

NITRIC OXIDE IMPROVES PULMONARY VASCULAR IMPEDANCE, TRANSPULMONARY EFFICIENCY, AND LEFT VENTRICULAR FILLING IN CHRONIC PULMONARY HYPERTENSION

Received for publication June 24, 1996 revisions requested Oct. 22, 1996; revisions received Nov. 5, 1996 accepted for publication Dec. 27, 1996. Address for reprints: Edward P. Chen, MD, Box 0470, S-343, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143.

Abstract

Objective: Chronic pulmonary hypertension is difficult to treat and despite the introduction of several therapeutic options, no single therapy is universally recommended. Nitric oxide has had some role clinically in improving pulmonary hemodynamics in this setting; however, basic investigation has not been performed in an appropriate large animal model of stable pulmonary hypertension. This study was designed to examine the effects of inhaled nitric oxide on pulmonary hemodynamics in the setting of a canine model of monocrotaline pyrrole–induced chronic pulmonary hypertension and used Fourier analysis for assessment of pulmonary vascular impedance. Methods: Sixteen mongrel dogs (22 to 25 kg) were used. Animals underwent percutaneous pulmonary artery catheterization to measure right-sided hemodynamics before and 6 weeks after a right atrial injection of either monocrotaline pyrrole (n = 8) or placebo (n = 8). Six weeks after the injection all hearts were instrumented with an ultrasonic flow probe, sonomicrometric dimension transducers, and micromanometers. Data were collected at baseline and after nitric oxide administration. Harmonic derivation of functional data was achieved with Fourier analysis. Results: Six weeks after the injection, significant increases in pulmonary artery pressure and pulmonary vascular resistance were observed in the monocrotaline pyrrole group. Nitric oxide led to significant decreases in pulmonary vascular impedance. Significant improvements in pulmonary blood flow, transpulmonary efficiency, and left ventricular filling were also observed. Conclusions: This investigation demonstrates the well-known clinical effects of nitric oxide in improving pulmonary hypertension, which were also associated with an increase in pulmonary blood flow, transpulmonary efficiency, and left ventricular filling in the setting of monocrotaline pyrrole–induced pulmonary hypertension.

This article has been cited by other articles:

				F. Akhavein, E. J. St.-Michel, E. Seifert, and C. V. Rohlicek Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats J Appl Physiol, July 1, 2007; 103(1): 287 - 295. [Abstract] [Full Text] [PDF]

				R.M.F. Berger Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects Eur. Heart J., January 1, 2000; 21(1): 17 - 27. [PDF]

				Y. M. W. Janssen, R. Soultanakis, K. Steece, E. Heerdt, R. J. Singh, J. Joseph, and B. Kalyanaraman Depletion of nitric oxide causes cell cycle alterations, apoptosis, and oxidative stress in pulmonary cells Am J Physiol Lung Cell Mol Physiol, December 1, 1998; 275(6): L1100 - L1109. [Abstract] [Full Text] [PDF]